# Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy

> **NCT05507476** · NA · COMPLETED · sponsor: **Zagazig University** · enrollment: 52 (actual)

## Conditions studied

- Anesthesia

## Interventions

- **DRUG:** Desmopressin Acetate Nasal, 10 μg/0.1 ml per spray
- **DRUG:** Epinephrine topical 1:100,000 Nasal Packs

## Key facts

- **NCT ID:** NCT05507476
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05507476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05507476, "Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05507476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*